Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1990 3
1991 8
1992 12
1993 10
1994 10
1995 9
1996 3
1997 4
1998 4
1999 9
2000 3
2001 7
2002 1
2003 3
2004 3
2005 3
2006 3
2007 3
2008 2
2009 2
2010 5
2012 3
2013 2
2014 6
2015 2
2016 7
2017 3
2018 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

125 results
Results by year
Filters applied: . Clear all
Page 1
Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study.
Gilbert DL, Murphy TK, Jankovic J, Budman CL, Black KJ, Kurlan RM, Coffman KA, McCracken JT, Juncos J, Grant JE, Chipkin RE. Gilbert DL, et al. Mov Disord. 2018 Aug;33(8):1272-1280. doi: 10.1002/mds.27457. Epub 2018 Sep 7. Mov Disord. 2018. PMID: 30192018 Clinical Trial.
A single-blind study of 'as-needed' ecopipam for gambling disorder.
Grant JE, Odlaug BL, Black DW, Fong T, Davtian M, Chipkin R, Kim SW. Grant JE, et al. Ann Clin Psychiatry. 2014 Aug;26(3):179-86. Ann Clin Psychiatry. 2014. PMID: 25166480 Clinical Trial.
125 results
Jump to page
Feedback